Results 111 to 120 of about 133,413 (200)

Proposing a Coverage With Evidence Development Framework for Accelerated Approval at the U.S. Food and Drug Administration. [PDF]

Pharmacoepidemiol Drug Saf
Bearelly D, Desai P, Zhu DT, Balkrishnan R.   +3 more
europepmc   +1 more source

Neovascularization and Neo-Endothelialization After Atrial Septal Defect Closure. [PDF]

JACC Case Rep
Lu YW, Wang KL, Newby DE.
europepmc   +1 more source

Translational opportunities in aptamer and nanobody lateral flow assays within the WHO REASSURED framework.

Sens Diagn
Monk ET, McConnell EM, McMullin DR, DeRosa MC.   +3 more
europepmc   +1 more source

When the Wire Doesn't Come Out: Lessons From a 24-Year Silent Migration. [PDF]

JACC Case Rep
Garg P.
europepmc   +1 more source

Response to "Reanalyzing the impact of cognitive training over 20 years in the ACTIVE study: Losing the forest in the trees". [PDF]

Alzheimers Dement (N Y)
Gross AL, Rebok GW, Albert MS.
europepmc   +1 more source

ADC Conjugation Strategies: From Technological Evolution to a Practical Selection Framework. [PDF]

Pharmaceutics
Kim S, Lee SR, Sohn MH, Lee K, Kim SW, Yoo H, Jeong H, Oh D, Chang J, Yun JA, Choi SY.   +10 more
europepmc   +1 more source

Revisiting clozapine-induced mania: When a case report informs clinical decisions. [PDF]

Dusunen Adam
Cholette-Tétrault S, Bakhshi M.
europepmc   +1 more source

Community trust, not resource pledges alone, will determine whether the DRC contains its seventeenth Ebola outbreak. [PDF]

New Microbes New Infect
Mohamed AA, Ahmed MM.
europepmc   +1 more source